PV Bulletin
SwissmedicSwitzerland

Checklist for the Inspection of Medical Device Vigilance in Hospitals

Swissmedic introduces a comprehensive checklist aimed at enhancing compliance with medical device vigilance standards in Swiss hospitals.

PV Impact Brief

Urgency: HighConfidence: high
Relevant for
Regulatory Intelligence LeadPV Quality Lead
Processes impacted
Inspection Readiness
Action needed

Healthcare facilities must utilize the new checklist during inspections to conduct gap analyses and ensure compliance with reporting requirements associated with their vigilance systems.

Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Policy change details

Document type
Checklist
Policy status
effective
Publication date
2026-07-17
Policy change
Swissmedic has published a new checklist for the inspection of materiovigilance (medical device vigilance) systems in hospitals. The tool is intended to help hospital facilities perform gap analyses and ensure compliance with GPMV-Spital requirements.

Key changes

Introduction of a formal checklist tool for hospital materiovigilance inspections, focusing on the reporting of incidents and the role of the vigilance contact person.

Affected workflows

Inspection Readiness

Responsible groups

Quality AssuranceComplianceMedical Device Safety

PV impact

Updates the inspection framework for medical device vigilance in Switzerland; hospitals and potentially associated MAH stakeholders should use the checklist to ensure incident reporting compliance.

View regulator source

Source document details

Exact policy details

Applicable Legislation
The health facility identifies and applies relevant laws and regulations for its operations.
Applies to: All healthcare facilities conducting medical device vigilance
1.3.1 · p. 1 · High · Source
Quality Management Responsibility
The management is responsible for implementing regulatory requirements regarding vigilance processes.
Applies to: Healthcare facility management
3.1, 3.3 · p. 1 · High · Source
Retention Period for Records
Documents related to materiovigilance must be retained for at least 15 years.
Applies to: All medical device documentation
3.7, 6.1, 6.10, 8.5 · p. 1 · High · Source
Notification of Serious Incidents
Serious incidents must be reported within 2, 10, or 15 days depending on the severity.
Applies to: Healthcare facilities reporting serious incidents
6.1, 6.6 · p. 1 · High · Source
Vigilance Contact Person
A vigilance contact person must be appointed and reported to Swissmedic.
Applies to: Every healthcare facility
3.3.2 · p. 1 · High · Source

Evidence and confidence

Confidence: highSource updated: Jul 17, 2026

Full briefing

What changed

The introduction of a formal checklist tool for hospital inspections regarding materiovigilance, enhancing standards for incident reporting and vigilance roles.

Why it matters

The checklist establishes a framework for hospitals and associated stakeholders to ensure vigilance compliance, thus improving patient safety and regulatory adherence in the handling of medical devices.

Practical implication

Healthcare facilities must utilize the new checklist during inspections to conduct gap analyses and ensure compliance with reporting requirements associated with their vigilance systems.

Related updates for your role

publicEuropean Medicines Agency · EU · Updated Jul 15, 2026

Reflection paper on particulars for safety signals for (traditional) herbal medicinal products

Urgency: High

Implement increased documentation and reporting processes for traditional herbal medicinal products. Ensure staff receive training on the complexities involved in signal management for these products.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead
verifiedRegulatory action: Draft Guidance
Read impact briefarrow_forward
publicCenter for Drug Evaluation (CDE), National Medical Products Administration (NMPA) · China · Updated Jul 14, 2026

Technical Guidelines for Communication on Real-World Evidence Supporting the Extension of Pediatric Indications for Marketed Drugs (Draft for Comments)

Urgency: High

Sponsors must implement early communication strategies with the CDE regarding RWE study plans as a prerequisite for pediatric indication extension submissions.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Consultation
Read impact briefarrow_forward
publicEuropean Medicines Agency · EU · Updated Jul 15, 2026

Updated eCTD v4.0 technical validation criteria

Urgency: High

All electronic PV submissions must undergo new validation checks in accordance with the updated criteria to ensure compliance and accuracy.

Country ComplianceICSRRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, QPPV
verifiedRegulatory action: Technical Guidance
Read impact briefarrow_forward
publicHealth Canada · Canada · Updated Jul 15, 2026

Order Providing for Reliance on Foreign Regulatory Authority Decisions for Certain Drugs (Ministerial Reliance Order)

Urgency: High

Manufacturers must demonstrate that any variances from the foreign authorized drugs do not adversely affect safety or effectiveness when filing for deeming under this new framework.

Country ComplianceSignal ManagementRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Signal Management Lead, QPPV
verifiedRegulatory action: Draft Guidance
Read impact briefarrow_forward
Checklist for the Inspection of Medical Device Vigilance in Hospitals | PV Bulletin